PT  - JOURNAL ARTICLE
AU  - Mo, Yin
AU  - Hernandez-Koutoucheva, Anastasia
AU  - Musicha, Patrick
AU  - Bertrand, Denis
AU  - Lye, David
AU  - Tek, Ng Oon
AU  - Fenlon, Shannon N.
AU  - Chen, Swaine L.
AU  - Lin, Ling Moi
AU  - Tang, Wen Ying
AU  - Barkham, Timothy
AU  - Nagarajan, Niranjan
AU  - Cooper, Ben S
AU  - Marimuthu, Kalisvar
TI  - Carriage duration of carbapenemase-producing <em>Enterobacteriaceae</em> in a hospital cohort - implications for infection control measures
AID  - 10.1101/19001479
DP  - 2019 Jan 01
TA  - medRxiv
PG  - 19001479
4099  - http://medrxiv.org/content/early/2019/07/24/19001479.short
4100  - http://medrxiv.org/content/early/2019/07/24/19001479.full
AB  - Carriage duration of carbapenemase-producing Enterobacteriaceae (CPE) is uncertain. We followed 21 CPE carriers over one year. Mean carriage duration was 86 (95%CrI= [60, 122]) days, with 98.5% (95%CrI= [95.0, 99.8]) probability of decolonization in one year. Antibiotic consumption was associated with prolonged carriage. CPE-carriers’ status should be reviewed yearly.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study is primarily supported by the Singapore Biomedical Research Council-Economic Development Board Industry alignment fund (Grant ref: IAF311018). MY is supported by the Singapore National Medical Research Council Research Fellowship (Grant ref: NMRC/Fellowship/0051/2017). BSC is supported by UK Medical Research Council / Department for International Development (Grant ref: MR/K006924/1). PM is supported by the JPI-AMR (MODERN) (Grant ref: C-17-0014). AH is supported by Wellcome Trust (Grant ref: 212630/Z/18/Z). The Mahidol-Oxford Tropical Medicine Research Unit is part of the Wellcome Trust Major Overseas Programme in SE Asia (Grant ref: 106698/Z/14/Z). Additional grant support was provided by the NMRC Clinician-Scientist Individual Research Grant (Grant ref: NMRC/CIRG/1463/2016 and NMRC/CIRG/1467/2017), Singapore Ministry of Education Academic Research Fund Tier 2 grant: New Delhi Metallo-Beta-Lactamase: A global multicentre, whole-genome study (Grant ref: MOE2015-T2-2-096), NMRC Collaborative Grant: Collaborative Solutions Targeting Antimicrobial Resistance Threats in Health Systems (CoSTAR-HS) (Grant ref: NMRC CGAug16C005), NMRC Clinician Scientist Award (Grant ref: NMRC/CSA-INV/0002/2016).Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.YesData is available on request to the corresponding author.